Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results

Authors

Mohammad Ammad Ud Din, Rochester Regional HealthFollow
Saad Jamshed, Rochester Regional HealthFollow
Mehul Patel, Rochester Regional HealthFollow

Department

Internal Medicine

Document Type

Article

Publication Title

Clinical Breast Cancer

First Page

153

Last Page

155

DOI

10.1016/j.clbc.2020.11.016

Volume

21

Issue

3

Publication Date

6-1-2021

PubMed ID

33358362

Recommended Citation

Ammad Ud Din, M., Jamshed, S., & Patel, M. (2021). Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results. Clinical Breast Cancer, 21 (3), 153-155. https://doi.org/10.1016/j.clbc.2020.11.016